Clinical trial
Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients…
NCT00212862 · Ortho Biotech Products, L.P., Industry · Completed
Key facts
| NCT number | NCT00212862 |
|---|---|
| Title | Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced Anemia |
| Official title | Dosing and Outcomes Study of Erythropoietic Stimulating Therapies |
| Acronym | DOSE |
| Lead sponsor | Ortho Biotech Products, L.P., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Anemia, Cancer |
| Intervention type | Other |
| Interventions | Patients with chemotherapy induced anemia |
| Enrollment | 2,130 |
| Start date | Dec 1, 2003 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Sep 21, 2005 |
| Last update posted | Jun 30, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: